Katherine Fierlbeck – författare

While almost all universal health coverage in Canada is provided under the Canada Health Act, there is Medicare coverage that is provided outside of the act. This is the first book to explain the nature of these boundary health services, why they exist, and how to navigate them in practice. The Boundaries of Medicare examines the complex range of public health care services and coverage arrangements that predate or have developed alongside the Canada Health Act. These provisions – including for workers' compensation, military personnel and veterans, incarcerated persons, migrants, and Indigenous Peoples – are often not well understood, even by those working at policy and delivery levels. Katherine Fierlbeck and Gregory Marchildon aim to improve understanding of these boundary services: why they were established, who is eligible for them, how services are provided, how they are paid for, and how they are managed within a multilevel governance system. They also look at the dramatic increase in virtual health care services since the onset of the COVID-19 pandemic and their relationship to the Canada Health Act.Explaining the origins, operations, and tensions of government-funded health care outside the Canada Health Act, The Boundaries of Medicare is an essential resource for policymakers, providers, administrators, and patients seeking to navigate Medicare in Canada.

Examining the changing nature of health care federalism within a competitive global context, Comparative Health Care Federalism provides a rich and nuanced account of the way in which the interplay of federal relationships impact health care within an array of systems. The editors have gathered together some of the leading international health policy scholars to provide detailed accounts of the dynamics of federal health policy-making within their respective jurisdictions. Complementing the theoretical and methodological objectives, this book provides a detailed, empirical description of the challenges faced by different states and the ways in which health policy-making works within the federal, quasi-federal, and functional federal systems presented. In chapters on the United States, Australia, Canada, Germany, Spain, Italy, Austria, the United Kingdom, the EU, India, China, Brazil, and the Russian Federation the authors consider what variables contribute to, and stand in the way of, the formation of robust and sustainable health care systems.

This new edition examines some of the philosophical and theoretical issues underlying the ‘democratic project’ which increasingly dominates the fields of comparative development and international relations. The first concern presented here is normative and epistemological: as democracy becomes more widely accepted as the political currency of legitimacy, the more broadly it is defined. But as agreement decreases regarding the definition of democracy, the less we are able to evaluate how it is working, or indeed whether it is working at all. The second issue is causal: what are the claims being made regarding how best to secure a democratic system in developing states? To what extent do our beliefs and expectations of how political relations ought to be governed distort our understanding of how democratic societies do in fact emerge; and, conversely, to what extent does our understanding of how democracy manifests itself temper our conception of what it ought to be?The volume will be of interest to those in international development studies, as well as political theorists with an interest in applied ethics.

Examining the changing nature of health care federalism within a competitive global context, Comparative Health Care Federalism provides a rich and nuanced account of the way in which the interplay of federal relationships impact health care within an array of systems. The editors have gathered together some of the leading international health policy scholars to provide detailed accounts of the dynamics of federal health policy-making within their respective jurisdictions. Complementing the theoretical and methodological objectives, this book provides a detailed, empirical description of the challenges faced by different states and the ways in which health policy-making works within the federal, quasi-federal, and functional federal systems presented. In chapters on the United States, Australia, Canada, Germany, Spain, Italy, Austria, the United Kingdom, the EU, India, China, Brazil, and the Russian Federation the authors consider what variables contribute to, and stand in the way of, the formation of robust and sustainable health care systems.

Despite notable variation in health care policy from province to province, most scholarship published on the health care system in Canada uses a broad national perspective. Focusing on the health care systems of individual Canadian provinces and territories, our new series, Health System Profiles, examines the social, political, economic, and epidemiological context of health care policy in each Canadian province. Turning a critical eye to the health care system in Nova Scotia, author Katherine Fierlbeck outlines the organizational and regulatory frameworks structuring provincial health care, while providing a detailed assessment of Nova Scotia’s health financing, physical infrastructure, service provision, and the efficacy of technological resources used in data tracking and health quality assessments. Structured for ease of comparison, Nova Scotia: A Health System Profile will, along with other volumes in the series, help scholars draw analytic evidence-based policy conclusions about the health system of Nova Scotia and other Canadian provinces and territories.

Despite notable variation in health care policy from province to province, most scholarship published on the health care system in Canada uses a broad national perspective. Focusing on the health care systems of individual Canadian provinces and territories, our new series, Health System Profiles, examines the social, political, economic, and epidemiological context of health care policy in each Canadian province. Turning a critical eye to the health care system in Nova Scotia, author Katherine Fierlbeck outlines the organizational and regulatory frameworks structuring provincial health care, while providing a detailed assessment of Nova Scotia’s health financing, physical infrastructure, service provision, and the efficacy of technological resources used in data tracking and health quality assessments. Structured for ease of comparison, Nova Scotia: A Health System Profile will, along with other volumes in the series, help scholars draw analytic evidence-based policy conclusions about the health system of Nova Scotia and other Canadian provinces and territories.

There is plenty of controversy surrounding pharmaceuticals, but it cannot be denied that the pharmaceutical industry is both socially beneficial and profitable. Regulators are expected to ensure that the economic success of the industry does not come at the expense of public safety, yet they have also assumed a cooperative role by providing advice on regulation and by targeting unmet medical needs. Concerns over regulatory standards, conflicts of interest, and the manipulation of information on drug safety and effectiveness have led to public mistrust and a greater need for transparency between the pharmaceutical industry and government regulators.Transparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry responsible for creating transparency in the industry, from development to market. The contributors to this volume examine the various mechanisms introduced to make the regulatory process more informative and situate these efforts within the larger project of enhancing the safety of drugs, vaccines, and other products.

There is plenty of controversy surrounding pharmaceuticals, but it cannot be denied that the pharmaceutical industry is both socially beneficial and profitable. Regulators are expected to ensure that the economic success of the industry does not come at the expense of public safety, yet they have also assumed a cooperative role by providing advice on regulation and by targeting unmet medical needs. Concerns over regulatory standards, conflicts of interest, and the manipulation of information on drug safety and effectiveness have led to public mistrust and a greater need for transparency between the pharmaceutical industry and government regulators.Transparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry responsible for creating transparency in the industry, from development to market. The contributors to this volume examine the various mechanisms introduced to make the regulatory process more informative and situate these efforts within the larger project of enhancing the safety of drugs, vaccines, and other products.